Presentations will be given by CEO
Agenda in brief:
· Strategy and realising opportunities Guido Oelkers
· Innovation management at Sobi Ravi Rao
· Internationalisation strategy Norbert Oppitz
· Financial update Henrik Stenqvist
· Wrap-up and live Q&A
The event will start at 13:00 and will be broadcast live.
The live webcast can be followed on: Sobi Capital Markets Day 2020 (https://url11.mailanyone.net/v1/?m=1klArz-0004gZ-5X&i=57e1b682&c=y12x2FlyXONu4lyDdqbS3v_seIVwScqbNxFqf51W1ldRiQbIfV48PV83cIWaTeI7916EyKovR_NocC-jFnKHl9RiavUP0EsWIavbicnqTl67VHvOMym7fOhNrxQrGfU2tmCNIn6ZT01dVXanP8hAsEXG--So8jbrnmQTDcR9lDsiy7_d11JKqG7ikqp9ohzJDfo4CA8-qxER0mPE7ql8CNpLok08xKoiiGhVd7BaH9QdyM4QGz16FfwlRO0C-HVf4wufDFffqJhoMgNc6aPNjMCXJQEYy2eROpVDRAnkElQ)
A Q&A session will follow the presentations.
Dial-in details for the conference call are:
Please visit sobi.com for more information.
Recordings of the presentations, and the presentations themselves, will be made available on the website, in the Investors section.
About Sobi
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,500 people across Europe, North America, the Middle East, Russia and North Africa. In 2019, Sobi's revenue amounted to SEK 14.2 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at www.sobi.com.
Contact
Paula Treutiger, Head of Communication & Investor Relations
+ 46 733 666 599
paula.treutiger@sobi.com
Postal address SE-112 76
Phone: 46 8 697 20 00 www.sobi.com
https://news.cision.com/swedish-orphan-biovitrum-ab/r/agenda--sobi-capital-markets-day-2020,c3250184
https://mb.cision.com/Main/14266/3250184/1345061.pdf
(c) 2020 Cision. All rights reserved., source